ESMO Live Roundtable "COVID-19 vaccines and cancer care: the known, the unknown and the unknowable"
Dear ESMO Members,
Following the roll out of the COVID-19 vaccination campaign throughout the European Union (EU), ESMO would like to invite you to a virtual Live Roundtable to provide expert opinion on the use of vaccines targeting the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) in patients with cancer.
While patients with cancer are likely to be immunised against COVID-19 at some point in the next future, evidence regarding vaccination of this population is limited, thus raising some concerns on its efficacy and safety among the oncology community.
To address these concerns, a panel of renowned experts in oncology, immunology and virology will discuss the science behind COVID-19 vaccines, the risks of their interaction with antineoplastic therapies and ideal timings of administration in cancer care, along with updates on other key aspects such as the ability of patients with cancer to mount an immune response and the duration of post-vaccination protection.
- Prof. Solange Peters, ESMO President, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
- Dr Ravindran Kanesvaran, National Cancer Centre Singapore, Singapore
- Prof. Uwe Gerd Liebert, Institute of Virology, Leipzig University, Leipzig, Germany
- Prof. Thomas Powles, Barts Cancer Institute, London, UK
- Prof. Leif Erik Sander, Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Germany
The event will be moderated by Ben Hirschler, writer and former global pharmaceuticals correspondent for Reuters.
At the end of the event, a Q&A session will give participants the opportunity to broaden the discussion further.
Since the European Medical Agency (EMA) approved the first vaccines targeting Sars-CoV-2 in December 2020, ESMO has promptly reacted by releasing ten statements on COVID-19 vaccination in patients with cancer.
Now that COVID-19 vaccines are being widely distributed, the Society is advocating for people with cancer to be considered as a high priority group by launching a call to action for Member States "Vaccinate. Monitor. Educate.” supported by over 30 organisations.
The ESMO Live Roundtable “COVID-19 vaccines and cancer care: the known, the unknown and the unknowable” is part of these efforts to guide medical oncologists to better support their patients during the pandemic.
Registration is free and will remain open during the event.
Thank you in advance for taking the time to join the event.